Richard E Carson Selected Research

Glycine Plasma Membrane Transport Proteins

3/2016	Comparative evaluation of two glycine transporter 1 radiotracers [11C]GSK931145 and [18F]MK-6577 in baboons.
12/2015	Measurement of Bmax and Kd with the glycine transporter 1 radiotracer ¹⁸F-MK6577 using a novel multi-infusion paradigm.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard E Carson Research Topics

Disease

19	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 09/2003
11	Schizophrenia (Dementia Praecox) 01/2020 - 02/2004
10	Cognitive Dysfunction 01/2024 - 01/2016
9	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022 - 02/2005
7	Neoplasms (Cancer) 11/2023 - 08/2003
7	Mental Disorders (Mental Disorder) 01/2023 - 08/2013
7	Wounds and Injuries (Trauma) 10/2021 - 09/2011
6	Parkinson Disease (Parkinson's Disease) 08/2023 - 12/2004
6	Major Depressive Disorder (Major Depressive Disorders) 01/2023 - 07/2006
5	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2024 - 01/2016
5	Alcoholism (Alcohol Abuse) 01/2022 - 05/2010
5	Obesity 01/2022 - 02/2014
5	Substance-Related Disorders (Drug Abuse) 03/2016 - 03/2013
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2020 - 06/2012
4	Temporal Lobe Epilepsy 10/2020 - 07/2005
4	Cocaine-Related Disorders (Cocaine Addiction) 01/2019 - 01/2010
3	Dementia (Dementias) 01/2024 - 01/2020
3	Bipolar Disorder (Manic Depressive Psychosis) 01/2023 - 07/2006
3	Neuroinflammatory Diseases 07/2017 - 09/2008
3	Anxiety Disorders (Anxiety Disorder) 01/2017 - 03/2013
3	Inflammation (Inflammations) 10/2015 - 04/2012
3	Mood Disorders (Mood Disorder) 08/2013 - 06/2010
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 06/2012 - 11/2010
2	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 07/2013
2	Type 2 Diabetes Mellitus (MODY) 01/2023 - 12/2018
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2022 - 11/2011
2	Stroke (Strokes) 01/2022 - 01/2019
2	Hypoxia (Hypoxemia) 01/2018 - 12/2017
2	Brain Neoplasms (Brain Tumor) 01/2016 - 07/2013
2	Panic Disorder (Panic Attack) 10/2008 - 01/2004
2	Atrophy 12/2007 - 07/2005
2	Memory Disorders (Memory Loss) 07/2006 - 09/2003
1	Neoplasm Metastasis (Metastasis) 11/2023
1	Medulloblastoma 11/2023
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 02/2023
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2022
1	Synucleinopathies 01/2022
1	Epilepsy (Aura) 10/2020
1	Hyperglycemia 01/2020

Drug/Important Bio-Agent (IBA)

11	Glycoproteins (Glycoprotein)IBA 01/2024 - 07/2017
10	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 02/2004
9	Proteins (Proteins, Gene)FDA Link 01/2024 - 11/2011
9	Serotonin (5 Hydroxytryptamine)IBA 01/2022 - 01/2004
8	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2016
7	Glutamic Acid (Glutamate)FDA Link 01/2022 - 08/2013
6	Metabotropic Glutamate 5 ReceptorIBA 01/2023 - 08/2013
4	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 12/2007
4	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2018
4	kappa Opioid Receptors (kappa Opioid Receptor)IBA 11/2021 - 03/2013
4	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2021 - 11/2014
4	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2020 - 01/2010
3	EnzymesIBA 10/2021 - 01/2016
3	Cocaine (Cocaine HCl)IBA 01/2021 - 06/2014
3	naxagolideIBA 01/2021 - 01/2020
3	CannabinoidsIBA 12/2020 - 12/2012
3	LigandsIBA 01/2018 - 10/2012
3	Anticonvulsants (Antiepileptic Drugs)IBA 02/2016 - 03/2006
3	Opioid Receptors (Opioid Receptor)IBA 02/2016 - 04/2013
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2023 - 01/2023
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2022 - 01/2022
2	Antidepressive Agents (Antidepressants)IBA 01/2022 - 08/2013
2	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2022 - 12/2011
2	GlucocorticoidsIBA 10/2021 - 01/2017
2	1- ((3- (methylpyridin- 4- yl)methyl)- 4- (3,4,5- trifluorophenyl)pyrrolidin- 2- oneIBA 01/2021 - 12/2019
2	dihydrotetrabenazineIBA 12/2018 - 10/2018
2	fluoromisonidazoleIBA 01/2018 - 12/2017
2	gamma-Aminobutyric Acid (GABA)IBA 01/2017 - 10/2008
2	Glycine Plasma Membrane Transport ProteinsIBA 03/2016 - 12/2015
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2016 - 10/2014
2	CytokinesIBA 10/2015 - 04/2012
2	Amphetamine (Amfetamine)FDA LinkGeneric 04/2015 - 02/2004
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 10/2014 - 12/2012
2	3- (6- methylpyridin- 2- ylethynyl)cyclohex- 2- enone- O- methyloximeIBA 01/2014 - 08/2013
2	EndotoxinsIBA 10/2012 - 04/2012
2	GABA-A Receptors (GABA(A) Receptor)IBA 06/2012 - 10/2008
2	Cholinergic Agents (Cholinergics)IBA 07/2006 - 09/2003
2	ApolipoproteinsIBA 07/2006 - 09/2003
1	PolymersIBA 11/2023
1	Temozolomide (Temodar)FDA LinkGeneric 11/2023
1	LSN3172176IBA 08/2023
1	3- amino- 4- (2- dimethylaminomethylphenylsulfanyl)benzonitrileIBA 02/2023
1	SAM-760IBA 02/2023
1	Glycogen Synthase Kinase 3IBA 01/2023
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2023
1	imidazoleIBA 01/2023
1	veliparibIBA 01/2023
1	SDMIBA 01/2023
1	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2022
1	2- (2- (dimethylaminomethylphenylthio))- 5- fluoromethylphenylamineIBA 01/2022
1	AD 5IBA 01/2022
1	Ketamine FDA LinkGeneric 01/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022
1	GR 89696IBA 11/2021
1	AS2471907IBA 10/2021
1	Oxidoreductases (Dehydrogenase)IBA 10/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	C-Reactive ProteinIBA 12/2020
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 01/2020

Therapy/Procedure

7	Therapeutics 01/2024 - 10/2006
6	Drug Therapy (Chemotherapy) 01/2022 - 07/2013